These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 26938200)

  • 1. Management of Hypoparathyroidism: Present and Future.
    Bilezikian JP; Brandi ML; Cusano NE; Mannstadt M; Rejnmark L; Rizzoli R; Rubin MR; Winer KK; Liberman UA; Potts JT
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2313-24. PubMed ID: 26938200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoparathyroidism.
    Al-Azem H; Khan AA
    Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):517-22. PubMed ID: 22863393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone therapy for hypoparathyroidism.
    Cusano NE; Rubin MR; Bilezikian JP
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism.
    Marcucci G; Della Pepa G; Brandi ML
    Expert Opin Drug Saf; 2017 May; 16(5):617-625. PubMed ID: 28332412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative hypoparathyroidism: medical and surgical therapeutic options.
    Walker Harris V; Jan De Beur S
    Thyroid; 2009 Sep; 19(9):967-73. PubMed ID: 19731978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocalcemic disorders.
    Bove-Fenderson E; Mannstadt M
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):639-656. PubMed ID: 30449546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.
    Kim ES; Keating GM
    Drugs; 2015 Jul; 75(11):1293-303. PubMed ID: 26177893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.
    Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M
    Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
    Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoparathyroidism.
    Mannstadt M; Bilezikian JP; Thakker RV; Hannan FM; Clarke BL; Rejnmark L; Mitchell DM; Vokes TJ; Winer KK; Shoback DM
    Nat Rev Dis Primers; 2017 Aug; 3():17055. PubMed ID: 28857066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of hypoparathyroidism with intact parathyroid hormone.
    Rubin MR; Sliney J; McMahon DJ; Silverberg SJ; Bilezikian JP
    Osteoporos Int; 2010 Nov; 21(11):1927-34. PubMed ID: 20094706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
    Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L
    J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of parathyroid hormone in hypoparathyroidism.
    Cusano NE; Rubin MR; Irani D; Sliney J; Bilezikian JP
    J Endocrinol Invest; 2013 Dec; 36(11):1121-7. PubMed ID: 24445125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoparathyroidism and pseudohypoparathyroidism.
    Maeda SS; Fortes EM; Oliveira UM; Borba VC; Lazaretti-Castro M
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):664-73. PubMed ID: 17117292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
    Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis.
    Liu XX; Zhu XY; Mei GH
    Horm Metab Res; 2016 Jun; 48(6):377-83. PubMed ID: 27254756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.
    Winer KK; Kelly A; Johns A; Zhang B; Dowdy K; Kim L; Reynolds JC; Albert PS; Cutler GB
    J Pediatr; 2018 Dec; 203():391-399.e1. PubMed ID: 30470382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mini-review: new therapeutic options in hypoparathyroidism.
    Cusano NE; Rubin MR; Sliney J; Bilezikian JP
    Endocrine; 2012 Jun; 41(3):410-4. PubMed ID: 22311174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
    Winer KK; Sinaii N; Reynolds J; Peterson D; Dowdy K; Cutler GB
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.